Colgate-Palmolive Co

Most Recent

  • uploads///sp
    Company & Industry Overviews

    Last Week’s Consumer Space: Which Stocks Were the Outliers?

    At the end of the fourth week of April 2016, the S&P Consumer Staples slightly outperformed the S&P 500 and the S&P Consumer Discretionary as a whole. Let’s see which stocks stood out.

    By Gabriel Kane
  • uploads///CLX SALES
    Consumer

    Analyzing Clorox’s Performance in the Fourth Fiscal Quarter

    Clorox (CLX) reported net sales of $1.7 billion, which fell short of analysts’ expectation. However, the net sales increased 2.7% YoY.

    By Amit Singh
  • uploads///detergent _
    Consumer

    Procter & Gamble Beats Third-Quarter Estimates

    Procter & Gamble (PG) posted stronger-than-expected third-quarter results on Tuesday, April 23.

    By Amit Singh
  • uploads///Cl Developed
    Earnings Report

    Colgate-Palmolive’s Developed Markets Remained a Drag in 1Q17

    Net sales in North America fell 5.0% in 1Q17, reflecting a strong decline in volumes coupled with lower pricing.

    By Amit Singh
  • uploads///CLX Sales Q
    Earnings Report

    Clorox’s Fiscal 2Q17 Sales Rose on Impressive Volumes

    Clorox (CLX) delivered sales of $1.4 billion in fiscal 2Q17. The sales were in line with the consensus Wall Street analysts’ sales estimates.

    By Sirisha Bhogaraju
  • uploads///CL Sales
    Consumer

    Will Colgate-Palmolive Sustain Sales Momentum in 1Q18?

    Analysts expect Colgate-Palmolive (CL) to report sales of $4.0 billion in 1Q18, which represents a YoY (year-over-year) rise of 6.6%.

    By Amit Singh
  • uploads///FQ preview sales
    Earnings Report

    Clorox’s Fiscal 2Q16 Revenue Is Estimated to Be $1.3 Billion

    For fiscal 2Q16, Wall Street analysts’ consensus revenue estimate for Clorox is ~$1.3 billion, a 3.4% rise from the same quarter last year.

    By Penny Morgan
  • uploads///Cl Margins
    Earnings Report

    What Drove Colgate-Palmolive’s Margins Growth in 1Q17?

    Colgate-Palmolive (CL) witnessed improved margins in 1Q17 despite soft sales thanks to its “Funding the Growth” initiative aimed at reducing costs and driving efficiency.

    By Amit Singh
  • uploads///PG Segment
    Consumer

    How Procter & Gamble’s Segments Performed in 3Q18

    Lower pricing adversely impacted Procter & Gamble’s (PG) sales across product segments amid increased competitive activity.

    By Amit Singh
  • uploads///CLX EPS
    Consumer

    Why Analysts Expect Clorox’s Earnings to Fall in Fiscal 2Q18

    Analysts expect Clorox to report adjusted earnings of $1.23 per share, a YoY (year-over-year) decline of 1.6%.

    By Amit Singh
  • uploads///CL ANR
    Consumer

    Why SunTrust Upgraded Colgate-Palmolive Stock

    On October 11, 2017, SunTrust Robinson Humphrey upgraded Colgate-Palmolive (CL) stock to a “buy” from “hold” and increased the target price.

    By Amit Singh
  • uploads///CL ANR
    Consumer

    Colgate-Palmolive: Analysts Maintain a ‘Hold’

    Wall Street analysts continue to maintain a “neutral” outlook on Colgate-Palmolive (CL) stock.

    By Amit Singh
  • uploads///pg pic
    Miscellaneous

    Will Procter & Gamble’s Sales Improve in Fiscal 2017?

    After generating lower sales for 11 consecutive quarters, Procter & Gamble (PG) managed to report flat sales growth in fiscal 1Q17.

    By Gabriel Kane
  • uploads///cl pm
    Company & Industry Overviews

    How Much Has Colgate-Palmolive Increased Its Dividend?

    Colgate-Palmolive (CL) has a market capitalization of $60.9 billion. CL rose by 0.37% to close at $68.23 per share as of March 10, 2016.

    By Gabriel Kane
  • uploads///CLX Rating
    Consumer

    Analysts Remain Neutral on Clorox Stock before 4Q17 Results

    Analysts covering Clorox (CLX) have rated the stock a 2.9 on a scale of one (strong buy) to five (strong sell) and maintain a neutral outlook.

    By Amit Singh
  • uploads///KMB EPS
    Consumer

    Will Cost Pressures Hurt KMB’s Q2 2018 EPS Growth Rate?

    Analysts expect Kimberly-Clark (KMB) to report adjusted EPS of $1.57 in the second quarter.

    By Amit Singh
  • uploads///PG Margins
    Company & Industry Overviews

    Procter & Gamble’s Margins Could Remain Muted

    Procter & Gamble’s management remains upbeat and expects productivity savings to drive its margins higher in coming quarters.

    By Amit Singh
  • uploads///CLX EPS
    Earnings Report

    What’s behind Clorox’s Fiscal 3Q17 Earnings Beat?

    The Clorox Company (CLX) reported its fiscal 3Q17 results on May 3, 2017. Its EPS (earnings per share) of $1.31 exceeded analysts’ consensus estimate of $1.30.

    By Amit Singh
  • uploads///clx anr
    Earnings Report

    How Do Analysts Rate Clorox and Its Peers?

    Of the 17 analysts covering Clorox Company (CLX), two analysts have rated the stock as a “buy” as of November 2.

    By Gabriel Kane
  • uploads///US Treasuries Yield Curve
    Company & Industry Overviews

    Job Reports Drive Up Treasury Yields

    US Treasury yields moved uniformly upwards across the yield curve in the week ended June 5, 2015.

    By David Ashworth
  • uploads///chd pm
    Company & Industry Overviews

    Deutsche Bank Downgrades Church & Dwight Company to ‘Hold’

    Church & Dwight (CHD) reported 3Q16 net sales of $870.7 million, a rise of 1.0% compared to net sales of $861.8 million in 3Q15.

    By Gabriel Kane
  • uploads///Chart
    Company & Industry Overviews

    Procter & Gamble: Global Giant in Household, Personal Products

    The Procter & Gamble Company, or P&G, is the largest household and personal products company in the world. It was established in 1837 by William Procter and James Gamble.

    By Penny Morgan
  • uploads///PG valuation
    Earnings Report

    How PG’s Valuation Compares to Peers

    As of April 18, Procter & Gamble (PG) was trading at a 12-month forward PE (price-to-earnings) ratio of 22.8x.

    By Amit Singh
  • uploads///pg pm
    Company & Industry Overviews

    Henkel Acquired Procter & Gamble’s Haircare Brands

    Procter & Gamble (PG) has a market cap of $224.1 billion. PG rose by 0.35% to close at $82.84 per share on March 3, 2016.

    By Gabriel Kane
  • uploads///Valuation_PG
    Miscellaneous

    How PG’s Valuation Looks Now

    As of March 8, PG was trading at a 12-month forward PE ratio of 22.7x. The company is now trading at a higher valuation multiple than the S&P 500 Index.

    By Amit Singh
  • uploads///Inventory
    Company & Industry Overviews

    How Is Clorox Improving Product Distribution?

    For distribution in the United States, Clorox (CLX) sells or markets its products primarily through mass retail outlets, e-commerce channels, wholesale distributors, and medical supply distributors.

    By Penny Morgan
  • uploads///
    Cannabis

    Cannabis Stocks Up, Broader Equity Market Falls

    Today, cannabis stocks are trading in the green despite the weakness in the broader market. The ETFMG Alternative Harvest ETF was up 2.5% as of 2:00 PM ET.

    By Rajiv Nanjapla
  • uploads///events
    Company & Industry Overviews

    Key Dates for Consumer Stocks in the First Week of October

    On September 28, Goldman Sachs upgraded Brown-Forman (BF-B) to “neutral” from “sell” and raised the target price to $56 from $51.

    By Sushree Mohanty
  • uploads///clx pm
    Company & Industry Overviews

    Why Did Clorox China Recall Some of Its Products?

    The Clorox Company (CLX) has a market cap of $15.0 billion. It fell 0.67% and closed at $115.48 per share on November 23, 2016.

    By Gabriel Kane
  • uploads///kleenex _
    Consumer

    Will Sales and Cost Headwinds Stall the Recovery in KMB Stock?

    Shares of Kimberly-Clark (KMB) have increased 8.5% since the company reported better-than-expected third-quarter results on October 22.

    By Amit Singh
  • uploads///cl pe
    Earnings Report

    How Does Colgate-Palmolive’s Valuation Compare?

    12-month forward price-to-earnings multiple As of January 17, Colgate-Palmolive (CL) was trading at a 12-month forward PE (price-to-earnings) multiple of 22.2x. The company is currently trading at a higher valuation multiple than the S&P 500, which has a forward PE of 17.6x, and the S&P 500 Consumer Staples, which has a forward PE of 20.3x. […]

    By Gabriel Kane
  • uploads///pg pm
    Company & Industry Overviews

    Procter & Gamble Kicked off the Campaign for Its Pantene Brand

    Procter & Gamble (PG) fell 1.8% to close at $83.58 per share during the second week of November 2016.

    By Gabriel Kane
  • uploads///Q Margins
    Macroeconomic Analysis

    Weak Currencies, but Consumer Packaged Goods Margins Improved

    The 1Q16 margins of consumer packaged goods (or CPG) companies sent strong signals. These companies have been investing heavily in innovative products and other growth initiatives.

    By Penny Morgan
  • uploads///toilet paper _
    Consumer

    What Could Stall the Recovery in Kimberly-Clark Stock?

    Kimberly-Clark (KMB) stock has recovered nearly 6% in the last two trading days.

    By Amit Singh
  • uploads///cannabis _
    Company & Industry Overviews

    Cannabis Stocks Had a Mixed Performance Last Week

    Cannabis ETFs traded on a largely negative note last week.

    By Mohit Oberoi, CFA
  • uploads///CL Sales
    Consumer

    What Dragged Colgate-Palmolive’s Sales Down in Q4?

    Colgate-Palmolive (CL) posted net sales of $3.8 billion, a decline of about 2% on a YoY (year-over-year) basis, as unfavorable currency rates hurt the top line by 5%.

    By Amit Singh
  • uploads///Trade Weighted US Dollar Index Major Currencies
    Macroeconomic Analysis

    Net Exports: Why They Matter and What Drives Them

    A country’s net exports measure the value of total exports less the value of its total imports. It’s positive if exports are larger in value than imports.

    By David Ashworth
  • uploads///avp pm
    Company & Industry Overviews

    Moody’s Downgraded Avon Products with a ‘Negative’ Outlook

    Avon Products (AVP) fell by 4.2% and closed at $3.85 per share at the end of the fourth week of June 2016.

    By Gabriel Kane
  • uploads///sharon mccutcheon  unsplash
    Company & Industry Overviews

    What’s behind Procter & Gamble’s Improving Dividend Trend?

    Procter & Gamble recently announced a 4% hike in its quarterly dividend to $0.72 per share.

    By Amit Singh
  • uploads///clx pm
    Company & Industry Overviews

    Barclays Upgraded Clorox to ‘Equal-Weight’

    On January 9, 2017, Barclays upgraded Clorox’s rating to “equal-weight” from “underweight.” It set the stock’s price target at $111.0 from $115.0 per share.

    By Gabriel Kane
  • uploads///Stock price
    Earnings Report

    Can Procter & Gamble’s Stock Price Gain Momentum?

    Procter & Gamble’s stock has consistently fallen since the beginning of 2015. However, the stock was able to sustain some gains until September.

    By Penny Morgan
  • uploads///Cl margins
    Earnings Report

    Why Colgate-Palmolive’s Margins May Improve in 2Q17

    Colgate-Palmolive (CL) has resorted to cost-cutting and productivity savings measures to drive margins growth.

    By Amit Singh
  • uploads///CLX Sales
    Consumer

    Why Clorox’s Top Line Could Continue to Impress in 2018

    Clorox (CLX) registered healthy volumes growth in the United States (SPY) in 2017, which differentiates it from its peers.

    By Amit Singh
  • uploads///KMB Margins
    Consumer

    Why Kimberly-Clark’s Gross Margins Fell Significantly in 1Q18

    Kimberly-Clark’s adjusted operating margin fell 140 basis points to 17.4%, reflecting a lower gross margin.

    By Amit Singh
  • uploads///CLX Sales
    Consumer

    Clorox Disappoints on Outlook

    Clorox (CLX) continued its strong top-line and bottom-line performances in fiscal 1Q18.

    By Amit Singh
  • uploads///KMB EPS
    Consumer

    Why Kimberly-Clark’s EPS Could Decline in Q1 2019

    Analysts expect Kimberly-Clark to post adjusted earnings of $1.54 per share in the first quarter of 2019, which implies a YoY decline of 9.9%.

    By Amit Singh
  • uploads///CL cost drivers
    Company & Industry Overviews

    How Colgate Is Maintaining Margins in the Face of Headwinds

    Colgate’s worldwide gross profit margin fell to 58.5% in 2014 from 58.6% in 2013.

    By Penny Morgan
  • uploads///Mon pol
    Macroeconomic Analysis

    G20 Summit: Divergent Monetary Policies in a Divergent World?

    G20 leaders recognized the divergence in monetary policies and pledged to communicate their policy decisions clearly. Monetary policy tightening in needed in some economies.

    By David Ashworth
  • uploads///CLX_volume
    Consumer

    What’s Behind Clorox’s Industry-Leading Sales Growth?

    The Clorox Company (CLX) has managed to generate industry-leading sales despite challenges.

    By Amit Singh
  • uploads///PG ANR
    Consumer

    Procter & Gamble Stock: Analysts’ Ratings Trend

    Of the 23 analysts covering Procter & Gamble stock, 74.0% recommend a “hold,” 22.0% recommend a “buy,” and 4.0% recommend a “sell.”

    By Amit Singh
  • uploads///KMb Margins
    Earnings Report

    Here’s What Drove Kimberly-Clark’s Margins in 1Q17

    Kimberly-Clark (KMB) generated about $110.0 million in cost savings in 1Q17 and remains on track to save about $400.0 million in 2017.

    By Amit Singh
  • uploads///Clorox
    Consumer

    Will the Rally in Clorox Stock Continue?

    The COVID-19 pandemic boosted Clorox’s (NYSE:CLX) sales. People started paying more attention to cleaning and sanitizing.

    By Sirisha Bhogaraju
  • uploads///iipr earnings
    Cannabis

    IIPR Acquires Another Property in Pennsylvania

    Innovative Industrial Properties has continued its aggressive expansion. IIPR acquired a new property in Pennsylvania from Holistic Industries.

    By Rajiv Nanjapla
  • uploads///Clorox Q Post
    Consumer

    Is Clorox a ‘Buy’ after Its Stellar Q3 Results?

    Clorox (NYSE:CLX) raised its outlook for 2020 after the company generated strong sales in the third quarter of fiscal 2020.

    By Sirisha Bhogaraju
  • uploads///Marijuana
    Cannabis

    Why Is There Optimism before Cresco Labs’ Q4 Earnings?

    Analysts expect Cresco Labs to report revenue of $43.7 million in the fourth quarter—YoY growth of 157.9% from $17.0 million in the fourth quarter of 2018.

    By Rajiv Nanjapla
  • uploads///procter and gamble earnings
    Consumer

    Procter & Gamble Delivers Mixed Q3 Results amid COVID-19

    Today, Procter & Gamble (NYSE:PG) announced better-than-expected earnings for the third quarter of fiscal 2020. The fiscal third quarter ended on March 31.

    By Sirisha Bhogaraju
  • uploads///Procter Gamble Stock
    Consumer

    Jefferies Upgraded Procter & Gamble and Kimberly Clark

    Jefferies is bullish about consumer staples giants Procter & Gamble (NYSE:PG) and Kimberly Clark (NYSE:KMB). The firm upgraded both of the stocks.

    By Sirisha Bhogaraju
  • uploads///clorox stock coronavirus
    Consumer

    Clorox Gets Rating Upgrade, Coronavirus Triggers Demand

    Clorox stock rose 4.1% on March 16, even though the US stock market crashed amid the coronavirus pandemic. JPMorgan Chase upgraded its rating.

    By Sirisha Bhogaraju
  • uploads///GGB_
    Cannabis

    Green Growth Brands: Analysts’ Ratings and Target Price

    Analysts expect Green Growth to become profitable in fiscal 2021. In fiscal 2020, they expect the company to report a negative EBITDA of $80.2 million.

    By Rajiv Nanjapla
  • uploads///KushCo_
    Cannabis

    What Do Analysts Recommend for KushCo Holdings?

    KushCo Holdings reported its Q1 earnings on January 8. KushCo reported revenue of $34.96 million, below analysts’ forecast of $41.5 million.

    By Rajiv Nanjapla
  • uploads///AdobeStock_
    Cannabis

    Illinois Wakes Up to Legalized Recreational Cannabis

    On June 25, Illinois governor J.B. Pritzker signed a bill approving marijuana use for everyone over 21 years old. The law became effective on January 1.

    By Margaret Patrick
  • uploads///AdobeStock__Editorial_Use_Only
    Consumer

    Why 2019 Wasn’t As Good As 2018 for Church & Dwight Stock

    Although Church & Dwight stock is trading in the green, it has lagged its peers and the broader markets. The stock didn’t repeat its 2018 performance.

    By Amit Singh
  • uploads///can_
    Cannabis

    Cannabis Sector Rounds Out the Week in the Green

    Yesterday, Ontario’s government announced that it was scrapping its cap on the number of private retail cannabis stores and moving toward a new system.

    By Rajiv Nanjapla
  • uploads///MedMen
    Cannabis

    Why MedMen Stock Rose More than 24% on Thursday

    The optimistic guidance and initiatives helped MedMen stock rise. On Thursday, the stock closed the day at 0.71 Canadian dollars.

    By Rajiv Nanjapla
  • uploads///Fire
    Cannabis

    Supreme Cannabis: Lower Target Price after Q1 Earnings

    Following Supreme Cannabis’s weak first-quarter performance, PI Financial and Canaccord Genuity lowered their target prices.

    By Rajiv Nanjapla
  • uploads///can
    Cannabis

    Cannabis Stocks Up despite Weak Equity Market

    Despite the weakness in the broader US equity market today, the cannabis sector is trading in the green. Let’s see who’s making big moves today.

    By Rajiv Nanjapla
  • uploads///AdobeStock__Editorial_Use_Only
    Consumer

    Procter & Gamble Stock: What’s Fueling the Growth?

    Procter & Gamble stock has generated a significant amount of wealth for investors this year. The company boosted shareholders’ returns.

    By Amit Singh
  • uploads///cresco_
    Cannabis

    Cresco Labs: Analysts’ Ratings Post Q3 Earnings

    Cresco Labs (CRLBF) (CL) reported its third-quarter earnings results after markets closed on November 26. Its stock has since fallen.

    By Rajiv Nanjapla
  • uploads///AdobeStock_
    Consumer

    Why Church & Dwight Stock Is Underperforming Its Peers

    Church & Dwight stock is lagging behind its peers by a wide margin so far this year. High valuation and moderating growth are to blame.

    By Amit Singh
  • uploads///cresco
    Cannabis

    Cresco Labs Missed Analysts’ Q3 Estimates

    Cresco Labs reported its third-quarter earnings on Tuesday after the market closed. The company missed analysts’ top-line and bottom-line estimates.

    By Rajiv Nanjapla
  • uploads///
    Cannabis

    Why Cannabis Stocks Are Trending Down Today

    Today, the cannabis sector was trading in the red despite the broader US equity market trading in the green. Here’s what’s going on.

    By Rajiv Nanjapla
  • uploads///cresco labs
    Cannabis

    Can Cresco Lab’s Q3 Earnings Drive the Cannabis Sector?

    As of November 22, Cresco Labs was trading at 7.65 Canadian dollars, which implies a fall of 30% since its second-quarter earnings on August 21.

    By Rajiv Nanjapla
  • uploads///cresco
    Cannabis

    Cresco Labs’ Q3 Results Are Coming Up: What to Know

    US-based vertically-integrated cannabis player Cresco Labs is set to report its fiscal 2019 third-quarter results on November 26.

    By Margaret Patrick
  • uploads///charlottes web
    Cannabis

    Charlotte’s Web: Analysts Cut Targets after Weak Q3

    Charlotte’s Web Holdings reported its fiscal 2019 third-quarter earnings results on November 13. Its revenue came in at $25.1 million.

    By Rajiv Nanjapla
  • uploads///
    Cannabis

    Charlotte’s Web: Q3 Earnings Missed Analysts’ Estimates

    Today, Charlotte’s Web Holdings (CWEB) (CWBHF) reported its third-quarter earnings. The company missed analysts’ revenue and EPS estimates.

    By Rajiv Nanjapla
  • Cannabis

    Cresco Labs Kicks Off Its Incubator Program in Illinois

    Cresco Labs launched its incubator program in Illinois on November 6. This program is part of Cresco’s Social Equity and Educational Development initiative.

    By Nivedha Elango
  • uploads///CB
    Cannabis

    Charlotte’s Web: Top Four Things to Know about the Stock

    Last month, Charlotte’s Web announced that it would partner with Nielsen to guide US retail companies on the growth of the CBD (cannabidiol) space.

    By Rajiv Nanjapla
  • uploads///AdobeStock__Editorial_Use_Only
    Consumer

    Why Colgate-Palmolive’s Q3 Earnings Failed to Impress

    Colgate-Palmolive released its third-quarter earnings results today. The company’s performance was mixed, irking investors.

    By Amit Singh
  • uploads///
    Cannabis

    Cannabis Sector in the Green despite Subdued Market

    While the US markets are subdued today, with the S&P 500 and Dow Jones both down, the cannabis sector is in the green. Here’s why.

    By Rajiv Nanjapla
  • uploads///AdobeStock_
    Consumer

    Why Procter & Gamble Stock Might Not Cool Off

    So far, Procter & Gamble stock has outperformed the broader markets by a wide margin. Procter & Gamble stock has risen 33.8% on a YTD basis.

    By Amit Singh
  • uploads///AdobeStock_
    Cannabis

    Cannabis Stocks Rise: CURLF, IIPR, ACB, WEED

    After closing in the red yesterday, the US equity market was trading marginally higher today. The cannabis sector is also up—and here’s why.

    By Rajiv Nanjapla
  • uploads///AdobeStock__Editorial_Use_Only
    Consumer

    Procter Gamble: Q1 Earnings Could Drive Its Stock

    Procter & Gamble (PG) is scheduled to announce its earnings for the first quarter of fiscal 2020 before the markets open on Tuesday.

    By Amit Singh
  • uploads///AdobeStock__Editorial_Use_Only
    Consumer

    Procter & Gamble: Fiscal 2020 Could Start Strong

    Procter & Gamble was up 27.9% YTD on October 16, outperforming the broader markets by a wide margin. PG plans to announce its Q1 earnings on October 22.

    By Amit Singh
  • uploads///Cresco Labs
    Cannabis

    Cresco Labs Stock Rises on Dispensary Approval

    Yesterday, Cresco Labs (CRLBF) (CL) announced it had received licenses for its five Illinois medical cannabis dispensaries to sell adult-use cannabis.

    By Rajiv Nanjapla
  • uploads///PG Organic sales
    Consumer

    P&G Beats Estimates and Posts Best Organic Sales in Decade

    P&G’s sales and EPS handily exceeded analysts’ expectations thanks to the robust organic sales growth.

    By Amit Singh
  • uploads///
    Cannabis

    Cannabis Roundup: HEXO, APHA, CRLBF, and CRON

    Hexo launched Original Stash, a value cannabis brand. Hexo’s CEO stated that the company intends to educate consumers and “disrupt the illicit market.”

    By Rajiv Nanjapla
  • uploads///
    Cannabis

    Cannabis Roundup: CL, IIPR, CRON, and HEXO

    At 12:50 PM ET, the S&P 500 Index and the Dow Jones Industrial Average were down 0.6% and 0.3%. Cannabis stocks showed mixed performances.

    By Rajiv Nanjapla
  • uploads///Procter Gamble
    Consumer

    Procter & Gamble Stock: Valuation Limits Upside

    Procter & Gamble stock trades at 24.7x its fiscal 2020 estimated core EPS of $4.85. The stock trades at 23.2x its fiscal 2021 estimated core EPS of $5.17.

    By Amit Singh
  • uploads///Church Dwight
    Consumer

    Church & Dwight Stock: Valuation Overshadows Growth

    Church & Dwight (CHD) stock has risen 9.5% on a YTD (year-to-date) basis as of September 13. However, the stock lags its peers by a wide margin.

    By Amit Singh
  • uploads///Procter Gamble stock
    Consumer

    Will Procter & Gamble Stock Sustain the Rally?

    While we expect sustained momentum in the base business to support Procter & Gamble stock, its valuation suggests otherwise.

    By Amit Singh
  • uploads///CL KMB
    Consumer

    CL and KMB: Why Their Upside May Be Capped

    CL and KMB stocks have outperformed the broader markets this year. However, any further upside in the stocks seems capped.

    By Amit Singh
  • uploads///CL
    Cannabis

    Cresco Labs: Target Price and Valuation Multiple

    Coverage on Cresco Labs has increased from seven analysts in July to nine in August. Six analysts favor a “strong buy,” and three recommend a “buy.”

    By Rajiv Nanjapla
  • uploads///Procter Gamble Stock
    Consumer

    Procter & Gamble Stock: What’s behind Its Solid Return?

    Procter & Gamble stock benefits from its strong organic sales. On average, the company’s organic sales have increased by 5% in the last four quarters.

    By Amit Singh
  • uploads///cresco
    Cannabis

    Cresco Labs’ Q2 Revenues Might Boost Its Stock Price

    For the second quarter, Cresco Labs reported revenues of $29.9 million, which beat analysts’ expectation of $27.9 million.

    By Rajiv Nanjapla
  • uploads///dividend stock
    Consumer

    Why These Dividend-Paying Consumer Stocks Look Attractive

    As the broader markets take a hit, dividend-paying consumer stocks seem like a safe bet due to the sector’s defensive nature.

    By Amit Singh
  • uploads///Colgate CL
    Consumer

    Colgate-Palmolive’s Q2 EPS Met Estimates

    Colgate-Palmolive (CL) announced its second-quarter results on July 26.

    By Amit Singh
  • uploads///Procter Gamble
    Consumer

    Procter & Gamble Will Likely Beat Q4 Estimates

    Procter & Gamble (PG) is scheduled to announce to its fourth-quarter earnings on July 30. We expect the company to beat analysts’ estimates.

    By Amit Singh
  • uploads///Colgate Palmolive
    Consumer

    What to Expect From Colgate-Palmolive in Q2

    Colgate-Palmolive will announce its second-quarter result on Friday. We expect higher net price realization to drive the company’s organic sales.

    By Amit Singh
  • uploads///soap _
    Miscellaneous

    Church & Dwight Continues to Outperform with Its Earnings Growth

    Church & Dwight’s (CHD) earnings have grown at a strong double-digit rate in the past several quarters and have outpaced those of its rivals. The company has surpassed Wall Street’s expectations in five out of the past six quarters.

    By Amit Singh
  • uploads///toothpaste _
    Miscellaneous

    Colgate-Palmolive’s Revenue Unlikely to Impress

    Whereas Colgate-Palmolive’s (CL) top line beat analysts’ estimate in the first quarter, it has missed their estimates in four of the past five quarters.

    By Amit Singh
    • CONNECT with Market Realist
    • Link to Facebook
    • Link to Twitter
    • Link to Instagram
    • Link to Email Subscribe
    Market Realist Logo
    Do Not Sell My Personal Information

    © Copyright 2021 Market Realist. Market Realist is a registered trademark. All Rights Reserved. People may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.